Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Klok

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Clinical Therapeutics|January 15, 2013
Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and SwedenRogier M Klok, Rose-Marie Lindkvist, Mats Ekelund, et al.
Applied and Environmental Microbiology|December 11, 2023
Process conditions affect microbial diversity and activity in a haloalkaline biodesulfurization systemSuyash Gupta, Rieks de Rink, Johannes B M Klok, et al.
The British Journal of Ophthalmology|November 26, 1998
Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitisA M Klok, L Luyendijk, M J Zaal, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term useR M Klok, M J Postma, B A van Hout, et al.
Expert Review of Vaccines|November 23, 2012
Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptionsRaymond A Farkouh, Rogier M Klok, Maarten J Postma, et al.
Water Research X|July 24, 2019
Development and validation of a physiologically based kinetic model for starting up and operation of the biological gas desulfurization process under haloalkaline conditionsKarine Kiragosyan, Johannes B M Klok, Karel J Keesman, et al.
Bioresource Technology|December 8, 2022
Anaerobic sulphide removal by haloalkaline sulphide oxidising bacteriaRikke Linssen, Thomas Slinkert, Cees J N Buisman, et al.
Clinical Therapeutics|May 17, 2003
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The NetherlandsBen A van Hout, Rogier M Klok, Jacobus R B J Brouwers, et al.
Environmental Science & Technology Letters|August 24, 2018
Bacteria as an Electron Shuttle for Sulfide OxidationAnnemiek Ter Heijne, Rieks de Rink, Dandan Liu, et al.
Trends in Biotechnology|January 20, 2023
Nutrient recovery and pollutant removal during renewable fuel production: opportunities and challengesMargo Elzinga, Desiree de Haan, Cees J N Buisman, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Clinical Therapeutics|January 15, 2013
Cost-effectiveness of a 10- versus 13-valent pneumococcal conjugate vaccine in Denmark and SwedenRogier M Klok, Rose-Marie Lindkvist, Mats Ekelund, et al.
Applied and Environmental Microbiology|December 11, 2023
Process conditions affect microbial diversity and activity in a haloalkaline biodesulfurization systemSuyash Gupta, Rieks de Rink, Johannes B M Klok, et al.
The British Journal of Ophthalmology|November 26, 1998
Elevated serum IL-8 levels are associated with disease activity in idiopathic intermediate uveitisA M Klok, L Luyendijk, M J Zaal, et al.
Alimentary Pharmacology & Therapeutics|May 21, 2003
Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term useR M Klok, M J Postma, B A van Hout, et al.
Expert Review of Vaccines|November 23, 2012
Cost-effectiveness models of pneumococcal conjugate vaccines: variability and impact of modeling assumptionsRaymond A Farkouh, Rogier M Klok, Maarten J Postma, et al.
Water Research X|July 24, 2019
Development and validation of a physiologically based kinetic model for starting up and operation of the biological gas desulfurization process under haloalkaline conditionsKarine Kiragosyan, Johannes B M Klok, Karel J Keesman, et al.
Bioresource Technology|December 8, 2022
Anaerobic sulphide removal by haloalkaline sulphide oxidising bacteriaRikke Linssen, Thomas Slinkert, Cees J N Buisman, et al.
Clinical Therapeutics|May 17, 2003
A pharmacoeconomic comparison of the efficacy and costs of pantoprazole and omeprazole for the treatment of peptic ulcer or gastroesophageal reflux disease in The NetherlandsBen A van Hout, Rogier M Klok, Jacobus R B J Brouwers, et al.
Environmental Science & Technology Letters|August 24, 2018
Bacteria as an Electron Shuttle for Sulfide OxidationAnnemiek Ter Heijne, Rieks de Rink, Dandan Liu, et al.
Trends in Biotechnology|January 20, 2023
Nutrient recovery and pollutant removal during renewable fuel production: opportunities and challengesMargo Elzinga, Desiree de Haan, Cees J N Buisman, et al.
Pageof 6